{"id":2583,"date":"2022-08-12T00:36:58","date_gmt":"2022-08-11T15:36:58","guid":{"rendered":"http:\/\/misterx95.myds.me\/?p=2583"},"modified":"2022-08-12T00:37:02","modified_gmt":"2022-08-11T15:37:02","slug":"2022-08-12","status":"publish","type":"post","link":"https:\/\/misterx95.myds.me\/wordpress\/?p=2583","title":{"rendered":"2022.08.12"},"content":{"rendered":"\n<h2>IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH<\/h2>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Xu+J&amp;cauthor_id=35686937\">Jun Xu<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Wang+Y&amp;cauthor_id=35686937\">Ya Wang<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Khoshdeli+M&amp;cauthor_id=35686937\">Mina Khoshdeli<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Peach+M&amp;cauthor_id=35686937\">Matt Peach<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Chuang+JC&amp;cauthor_id=35686937\">Jen-Chieh Chuang<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Lin+J&amp;cauthor_id=35686937\">Julie Lin<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tsai+WW&amp;cauthor_id=35686937\">Wen-Wei Tsai<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mahadevan+S&amp;cauthor_id=35686937\">Sangeetha Mahadevan<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Minto+W&amp;cauthor_id=35686937\">Wesley Minto<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Diehl+L&amp;cauthor_id=35686937\">Lauri Diehl<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Gupta+R&amp;cauthor_id=35686937\">Ruchi Gupta<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Trauner+M&amp;cauthor_id=35686937\">Michael Trauner<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Patel+K&amp;cauthor_id=35686937\">Keyur Patel<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Noureddin+M&amp;cauthor_id=35686937\">Mazen Noureddin<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kowdley+KV&amp;cauthor_id=35686937\">Kris V Kowdley<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Gulamhusein+A&amp;cauthor_id=35686937\">Aliya Gulamhusein<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bowlus+CL&amp;cauthor_id=35686937\">Christopher L Bowlus<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Huss+RS&amp;cauthor_id=35686937\">Ryan S Huss<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Myers+RP&amp;cauthor_id=35686937\">Robert P Myers<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Chung+C&amp;cauthor_id=35686937\">Chuhan Chung<\/a><sup>\u00a0<\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Billin+AN&amp;cauthor_id=35686937\">Andrew N Billin<\/a><sup>\u00a0<\/sup><\/p>\n\n\n\n<h2>Abstract<\/h2>\n\n\n\n<p><strong>Background and aims:&nbsp;<\/strong>Pruritus is associated with multiple liver diseases, particularly those with cholestasis, but the mechanism remains incompletely understood. Our aim was to evaluate serum IL-31 as a putative biomarker of pruritus in clinical trials of an farnesoid X receptor (FXR) agonist, cilofexor, in patients with NASH, primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC).<\/p>\n\n\n\n<p><strong>Approach and results:&nbsp;<\/strong>Serum IL-31 was measured in clinical studies of cilofexor in NASH, PSC, and PBC. In patients with PSC or PBC, baseline IL-31 was elevated compared to patients with NASH and healthy volunteers (HVs). IL-31 correlated with serum bile acids among patients with NASH, PBC, and PSC. Baseline IL-31 levels in PSC and PBC were positively correlated with Visual Analog Scale for pruritus and 5-D itch scores. In patients with NASH, cilofexor dose-dependently increased IL-31 from Week (W)1 to W24. In patients with NASH receiving cilofexor 100 mg, IL-31 was higher in those with Grade 2-3 pruritus adverse events (AEs) than those with Grade 0-1 pruritus AEs. IL-31 weakly correlated with C4 at baseline in patients with NASH, and among those receiving cilofexor 100 mg, changes in IL-31 and C4 from baseline to W24 were negatively correlated. IL-31 messenger RNA (mRNA) was elevated in hepatocytes from patients with PSC and NASH compared to HVs. In a humanized liver murine model, obeticholic acid increased IL-31 mRNA expression in human hepatocytes and serum levels of human IL-31.<\/p>\n\n\n\n<p><strong>Conclusions:\u00a0<\/strong>IL-31 levels correlate with pruritus in patients with cholestatic disease and NASH, with FXR agonist therapy resulting in higher serum levels in the latter group. IL-31 appears to derive in part from increased hepatocyte expression. These findings have therapeutic implications for patients with liver disease and pruritus.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-file\"><a href=\"http:\/\/misterx95.myds.me\/wordpress\/wp-content\/uploads\/2022\/08\/IL-31-levels-correlate-with-pruritus-in-patients-with-cholestatic-and-metabolic-licer-diseases-and-is-farsenoid-X-receptor-responsive-in-NASH.pdf\">IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH<\/a><a href=\"http:\/\/misterx95.myds.me\/wordpress\/wp-content\/uploads\/2022\/08\/IL-31-levels-correlate-with-pruritus-in-patients-with-cholestatic-and-metabolic-licer-diseases-and-is-farsenoid-X-receptor-responsive-in-NASH.pdf\" class=\"wp-block-file__button\" download>Download<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a href=\"http:\/\/misterx95.myds.me\/wordpress\/wp-content\/uploads\/2022\/08\/Supplementary-dats.docx\">Supplementary Data<\/a><a href=\"http:\/\/misterx95.myds.me\/wordpress\/wp-content\/uploads\/2022\/08\/Supplementary-dats.docx\" class=\"wp-block-file__button\" download>Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH Jun Xu\u00a0,\u00a0Ya Wang\u00a0,\u00a0Mina Khoshdeli\u00a0,\u00a0Matt Peach\u00a0,\u00a0Jen-Chieh Chuang\u00a0,\u00a0Julie Lin\u00a0,\u00a0Wen-Wei Tsai\u00a0,\u00a0Sangeetha Mahadevan\u00a0,\u00a0Wesley Minto\u00a0,\u00a0Lauri Diehl\u00a0,\u00a0Ruchi Gupta\u00a0,\u00a0Michael Trauner\u00a0,\u00a0Keyur Patel\u00a0,\u00a0Mazen Noureddin\u00a0,\u00a0Kris V Kowdley\u00a0,\u00a0Aliya Gulamhusein\u00a0,\u00a0Christopher L Bowlus\u00a0,\u00a0Ryan S Huss\u00a0,\u00a0Robert P Myers\u00a0,\u00a0Chuhan Chung\u00a0,\u00a0Andrew N Billin\u00a0 Abstract Background and aims:&nbsp;Pruritus is associated with [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2583"}],"collection":[{"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2583"}],"version-history":[{"count":1,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2583\/revisions"}],"predecessor-version":[{"id":2586,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2583\/revisions\/2586"}],"wp:attachment":[{"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/misterx95.myds.me\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}